文献速递慢性静脉疾病

超声引导泡沫硬化剂治疗下肢浅静脉功能不全安全有效

Ultrasound-guided foam sclerotherapy is safe and effective in the management of superficial venous insufficiency of the lower extremity.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-01-01

本文通过检索PubMed并分析临床试验与系统综述,总结超声引导泡沫硬化剂(UGFS)的技术要点与疗效。UGFS在大隐静脉疾病中技术成功率低于热消融和手术,再治疗更常见,但患者报告的生活质量改善相似;用于属支静脉联合热消融时成功率高、满意度好,安全性与其他方法相当或更优。

要点

  • 泡沫制备以空气与硬化剂1:3或1:4比例、低硅胶低容量注射器系统为佳。
  • UGFS治疗大隐静脉技术成功率低于热消融和手术,再治疗更常见。
  • UGFS用于属支静脉联合主干热消融时成功率高、患者满意度好。

核心结论

  • 采用正确技术时,UGFS治疗下肢浅静脉疾病安全有效。

研究设计与样本

  • 通过PubMed检索超声引导泡沫硬化剂(UGFS)相关文献,审阅所有摘要以筛选临床试验和系统综述进行全文分析,并补充检索所选研究的参考文献。

主要发现

  • UGFS治疗大隐静脉疾病的技术成功率低于热消融和手术,再治疗更常见。
  • UGFS与热消融、手术三种方式的患者报告生活质量改善相似。
  • UGFS用于属支静脉联合主干热消融时成功率高,患者满意度好。
  • UGFS安全性与其他方式相当或更优。

关键数值与推荐

  • 泡沫制备以空气与硬化剂1:3或1:4比例在低硅胶、低容量注射器系统中为佳。
  • 生理性气体可能减少副作用,但泡沫稳定性下降。
  • 适当无菌与清洁方案对安全有效治疗至关重要。

临床怎么用

  • UGFS可用于下肢浅静脉功能不全,尤其适合属支静脉联合主干热消融。
  • 实施UGFS需注意泡沫制备比例、注射器系统选择及无菌操作。
  • 对大隐静脉主干病变,需权衡UGFS技术成功率较低和再治疗风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Superficial venous disease of the lower extremity has a significant impact on quality of life. Both truncal and tributary vein reflux contribute to this disease process. Endovenous foam sclerotherapy is a widely used technique throughout the world for the management of superficial venous reflux and ultrasound guidance improves its safety and efficacy. METHODS: A PubMed search for ultrasound-guided foam sclerotherapy (UGFS) was conducted and all abstracts were reviewed to identify clinical trials and systematic reviews for a full-text analysis. Additional articles were also identified through searching the references of the selected studies. RESULTS: The production of foam for sclerotherapy in a 1:3 or 1:4 ratio of air to sclerosant is optimal in a low silicone, low-volume syringe system. Physiologic gas may decrease any side effects, with the trade-off of decreased foam stability. Proper technique with appropriate sterility and cleansing protocols are paramount for safe and effective treatment. The technical success of UGFS for great saphenous vein disease is inferior to endothermal and surgical modalities and retreatment is more common. However, the clinical improvement in patient-reported quality of life is similar between these three modalities. When used for tributary veins in combination with endothermal approaches of the truncal veins, UGFS has high rates of success with excellent patient satisfaction. UGFS has demonstrated an excellent safety profile comparable with or superior to other modalities. CONCLUSIONS: With proper technique, UGFS is safe and effective for the management of superficial venous disease.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Cartee TV, Wirth P, Greene A, et al. Ultrasound-guided foam sclerotherapy is safe and effective in the management of superficial venous insufficiency of the lower extremity. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34144767. doi:10.1016/j.jvsv.2021.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。